Mine Cicek, PhD

Associate Professor, Rochester, MN, Laboratory Medicine and Pathology

EmailCicek.Mine@mayo.edu

2336 Citations
27 Scopus h-Index

If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Mine Cicek is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

9 Similar Profiles

Ovarian Neoplasms Medicine & Life Sciences

Prostatic Neoplasms Medicine & Life Sciences

Genes Medicine & Life Sciences

Single Nucleotide Polymorphism Medicine & Life Sciences

Germ-Line Mutation Medicine & Life Sciences

Case-Control Studies Medicine & Life Sciences

Odds Ratio Medicine & Life Sciences

Genotype Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2018

2336 Citations
27 Scopus h-Index
43 Article
2 Chapter

1 Citation (Scopus)

Association of mitochondrial DNA copy number with self-rated health status

Takahashi, P. Y., Jenkins, G. D., Welkie, B. P., McDonnell, S. K., Evans, J. M., Cerhan, J. R., Olson, J. E., Thibodeau, S. N., Cicek, M. & Ryu, E., Jan 1 2018, In : Application of Clinical Genetics. 11, p. 121-127 7 p.

Research output: Contribution to journal › Article

Mitochondrial DNA

Health Status

Health

Comorbidity

Biomarkers

19 Citations (Scopus)

Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene

AOCS study group, Feb 7 2017, In : Oncotarget. 8, 31, p. 50930-50940 11 p.

Research output: Contribution to journal › Article

Exome

Neoplasm Genes

Ovarian Neoplasms

Genes

Mutation

21 Citations (Scopus)

PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations

Ovarian Cancer Association Consortium & Australian Ovarian Cancer Study Group, Mar 1 2016, In : Journal of the National Cancer Institute. 108, 3, djv347.

Research output: Contribution to journal › Article

Phosphoprotein Phosphatases

Ovarian Neoplasms

Mutation

High-Throughput Nucleotide Sequencing

Therapeutics

115 Citations (Scopus)

Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population

Song, H., Dicks, E., Ramus, S. J., Tyrer, J. P., Intermaggio, M. P., Hayward, J., Edlund, C. K., Conti, D., Harrington, P., Fraser, L., Philpott, S., Anderson, C., Rosenthal, A., Gentry-Maharaj, A., Bowtell, D. D., Alsop, K., Cicek, M., Cunningham, J. M., Fridley, B. L., Alsop, J. & 19 others, Jimenez-Linan, M., Høgdall, E., Høgdall, C. K., Jensen, A., Kjaer, S. K. R., Lubiński, J., Huzarski, T., Jakubowska, A., Gronwald, J., Poblete, S., Lele, S., Sucheston-Campbell, L., Moysich, K. B., Odunsi, K., Goode, E. L., Menon, U., Jacobs, I. J., Gayther, S. A. & Pharoah, P. D. P., Sep 10 2015, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33, 26, p. 2901-2907 7 p.

Research output: Contribution to journal › Article

Germ-Line Mutation

Ovarian Neoplasms

Mutation

Population

Genes

138 Citations (Scopus)

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer

AOCS study group & Ovarian Cancer Association Consortium, Nov 1 2015, In : Journal of the National Cancer Institute. 107, 11

Research output: Contribution to journal › Article

Germ-Line Mutation

Ovarian Neoplasms

Genes

Confidence Intervals

Mutation